Canergy 100 mg Tablets for Dogs

국가: 영국

언어: 영어

출처: VMD (Veterinary Medicines Directorate)

유효 성분:

Propentofylline

제공처:

Le Vet Beheer B.V.

ATC 코드:

QC04AD90

INN (국제 이름):

Propentofylline

약제 형태:

Tablet

처방전 유형:

POM-V - Prescription Only Medicine – Veterinarian

치료 그룹:

Dogs

치료 영역:

Cardio Vascular

승인 상태:

Authorized

승인 날짜:

2015-05-21

제품 특성 요약

Revised: May 2020
AN: 01081/2019
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Canergy 100 mg tablets for dogs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains :
ACTIVE SUBSTANCE:
Propentofylline
100 mg
EXCIPIENTS:
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Tablet.
Light brown with brown spots, round and convex flavoured tablet with a
cross-
shaped break line on one side.
The tablets can be divided into 2 or 4 equal parts.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the improvement of peripheral and cerebral vascular blood
circulation. For
improvement in dullness, lethargy and overall demeanour in dogs_._
4.3
CONTRAINDICATIONS
Do not use in dogs weighing less than 5 kg.
Do not use in known cases of hypersensitivity to the active substance
or to any
of the excipients.
See also section 4.7
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
Revised: May 2020
AN: 01081/2019
Page 2 of 5
4.5
SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
Specific diseases (e.g. kidney disease) should be treated accordingly.
Consideration should be given to rationalising the medication of dogs
already
receiving treatment for congestive heart failure or bronchial disease.
In the case of renal failure, the dose should be reduced.
The tablets are flavoured. In order to avoid any accidental ingestion,
store
tablets out of reach of the animals.
Special precautions to be taken by the person administering the
veterinary
medicinal product to animals
Care should be taken to avoid accidental ingestion.
In the event of accidental ingestion of the tablets, seek medical
advice
immediately and show the package leaflet or the label to the
physician. Wash
hands after use.
Any unused tablet portion should be returned to the open blister and
inserted back
into the carton to be used for the next administration.
4.6
ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
On rare occasions (more